| Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts A Pilotto, S Heinzel, U Suenkel, S Lerche, K Brockmann, B Roeben, ... Movement Disorders 32 (7), 1025-1034, 2017 | 92 | 2017 |
| Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum C Wilke, O Preische, C Deuschle, B Roeben, A Apel, C Barro, L Maia, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (11), 1270-1272, 2016 | 81 | 2016 |
| Progressive deafness–dystonia due to SERAC1 mutations: A study of 67 cases RR Maas, K Iwanicka‐Pronicka, S Kalkan Ucar, B Alhaddad, M AlSayed, ... Annals of neurology 82 (6), 1004-1015, 2017 | 61 | 2017 |
| Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies K Brockmann, C Quadalti, S Lerche, M Rossi, I Wurster, S Baiardi, ... Acta neuropathologica communications 9, 1-11, 2021 | 57 | 2021 |
| A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design, and baseline data G Pagano, FG Boess, KI Taylor, B Ricci, B Mollenhauer, W Poewe, ... Frontiers in neurology 12, 705407, 2021 | 52 | 2021 |
| Prodromal markers in Parkinson’s disease: limitations in longitudinal studies and lessons learned S Heinzel, B Roeben, Y Ben-Shlomo, S Lerche, G Alves, P Barone, ... Frontiers in aging neuroscience 8, 147, 2016 | 51 | 2016 |
| The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBA S Lerche, C Schulte, I Wurster, G Machetanz, B Roeben, M Zimmermann, ... Movement Disorders 36 (5), 1216-1228, 2021 | 50 | 2021 |
| Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha‐Synuclein Profiles S Lerche, I Wurster, B Roeben, M Zimmermann, B Riebenbauer, ... Movement Disorders 35 (3), 495-499, 2020 | 44 | 2020 |
| CSF NFL in a longitudinally assessed PD cohort: age effects and cognitive trajectories S Lerche, I Wurster, B Röben, M Zimmermann, G Machetanz, S Wiethoff, ... Movement Disorders 35 (7), 1138-1144, 2020 | 42 | 2020 |
| Insulin-like growth factor 1 (IGF-1) in Parkinson's disease: potential as trait-, progression-and prediction marker and confounding factors FP Bernhard, S Heinzel, G Binder, K Weber, A Apel, B Roeben, ... PLoS One 11 (3), e0150552, 2016 | 40 | 2016 |
| SERAC1 deficiency causes complicated HSP: evidence from a novel splice mutation in a large family B Roeben, R Schüle, S Ruf, B Bender, B Alhaddad, T Benkert, T Meitinger, ... Journal of medical genetics 55 (1), 39-47, 2018 | 38 | 2018 |
| Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha‐synuclein profile S Lerche, G Machetanz, I Wurster, B Roeben, M Zimmermann, A Pilotto, ... Movement Disorders 34 (7), 1069-1073, 2019 | 33 | 2019 |
| The motor band sign in ALS: presentations and frequencies in a consecutive series of ALS patients B Roeben, C Wilke, B Bender, U Ziemann, M Synofzik Journal of the Neurological Sciences 406, 116440, 2019 | 32 | 2019 |
| Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease-Report of the JPND Working Group BioLoC-PD S Lerche, I Liepelt-Scarfone, G Alves, P Barone, S Behnke, Y Ben-Shlomo, ... Neuroepidemiology 45 (4), 282-297, 2015 | 30 | 2015 |
| Assessment of cognitive‐driven activity of daily living impairment in non‐demented Parkinson's patients S Becker, A Bäumer, W Maetzler, S Nussbaum, M Timmers, L Van Nueten, ... Journal of Neuropsychology 14 (1), 69-84, 2020 | 26 | 2020 |
| A neurodegenerative vascular burden index and the impact on cognition S Heinzel, I Liepelt-Scarfone, B Roeben, I Nasi-Kordhishti, U Suenkel, ... Frontiers in aging neuroscience 6, 161, 2014 | 26 | 2014 |
| Effects of exergaming on hippocampal volume and brain‐derived neurotrophic factor levels in Parkinson’s disease E Schaeffer, B Roeben, O Granert, A Hanert, I Liepelt‐Scarfone, E Leks, ... European journal of neurology 29 (2), 441-449, 2022 | 25 | 2022 |
| Reasons for mild parkinsonian signs–Which constellation may indicate neurodegeneration? S Lerche, K Brockmann, I Wurster, A Gaenslen, B Roeben, D Holz, ... Parkinsonism & related disorders 21 (2), 126-130, 2015 | 25 | 2015 |
| Intraindividual neurofilament dynamics in serum mark the conversion to sporadic Parkinson's disease C Wilke, MCT Dos Santos, C Schulte, C Deuschle, D Scheller, ... Movement Disorders 35 (7), 1233-1238, 2020 | 22 | 2020 |
| Parkinson’s disease: evolution of cognitive impairment and CSF Aβ1–42 profiles in a prospective longitudinal study S Lerche, I Wurster, B Röben, G Machetanz, M Zimmermann, F Bernhard, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (2), 165-170, 2019 | 21 | 2019 |
